Abstract:ABSTRACT We aimed to investigate the epidemiological characteristics of non-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) respiratory pathogens among patients with acute respiratory infections (ARIs) in Shijiazhuang, China, during the coronavirus disease 2019 (COVID‐19) pandemic (January 2021-–December 2022) and after the relaxation of COVID‐19 restrictive measures (January 2022-–December 2023). This retrospective study enrolled 6,633 ARIs patients who visited the Hebei General Hospital between 2021- and 2023. Nasopharyngeal swabs samples were collected for multiplex PCR detection of 13 common respiratory pathogens. Respiratory pathogens were detected in 31.58% of individuals diagnosed with ARIs, whileereas a co-infection with multiple pathogens was observed in 8.5% of the ARI patients. In the years 2021 and 2022, 326 (27.63%) and 283 (24.38%) respiratory pathogens were found to be positive, respectively, during the COVID-19 pandemic. However, in 2023, subsequent to the easing of COVID-19 restrictions, the positivity rate significantly rose to 34.62%, with 4,292 cases identified. The majority of positive cases over the last three3 years were concentrated in patients under 14 years old. The predominant pathogens identified were human rhinovirus (HRVs) (15.08%) in 2021, mycoplasma pneumonia (MP) (6.46%) in 2022, and influenza A virus (FluA) (11.35%) in 2023. Seasonal prevalence patterns of most pathogens were affected, except for parainfluenza virus (PIV). There was a simultaneous increase in the positive cases and positivity rates of FluA and adenovirus (ADV) Iin 2023, compared to 2021 and 2022. Additionally, the infection rates of respiratory syncytial virus (RSV), MP, and coronavirus (CoV) in 2023 either exceeded or were comparable to those in 2021 and 2022. Conversely, the positivity rates of PIV, RVs, metapneumovirus (MPV), and influenza B virus (FluB) were lower in 2023 compared to 2021 or 2022. IMPORTANCE The implementation of strict non-pharmaceutical interventions (NPIs) during the coronavirus disease 2019 (COVID-19) pandemic may lead to changes in the epidemiological features of respiratory pathogens, as well as the occurrence of immune debt, potentially causing a resurgence in respiratory pathogen activity following the easing of strict NPIs measures. There are limited reports on the epidemiological characteristics of respiratory pathogens among patients of all ages with acute respiratory infections (ARIs) during the COVID-19 pandemic and after the easing of COVID-19 restrictions. Our study investigated the epidemiology of 13 respiratory pathogens in Shijiazhuang, China, from January 2021 to December 2023. Thisese data isare crucial for the ongoing surveillance of epidemiological shifts in respiratory pathogens during and post the -COVID-19 pandemic, and serves as a scientific foundation for the prevention and management of ARIs.

Post-pandemic Trends: Epidemiological and Etiological Insights into Acute Respiratory Infections in Southern China

Viral Pathogens of Acute Lower Respiratory Tract Infection in China.

Epidemiology of respiratory pathogens in patients with acute respiratory infections during the COVID‐19 pandemic and after easing of COVID‐19 restrictions

Viral and Atypical Pathogen's Epidemiology of a Large Cohort of Patients with Acute Respiratory Tract Infections in Shaanxi Province, Northwest China

Change of Epidemiological Characteristics of Four Respiratory Viral Infections in Children Before and During COVID-19 Pandemic.

Epidemiological characteristics and meteorological factors of acute respiratory infections (ARIs) in hospitalized children in eastern Guangdong, China

Epidemiological characteristics of respiratory viruses in patients with acute respiratory infections during 2009–2018 in southern China

Epidemiological changes in respiratory pathogen transmission among children with acute respiratory infections during the COVID-19 pandemic in Kunming, China

Respiratory Viruses and Mycoplasma Pneumoniae Surveillance among Hospitalized Children with Acute Respiratory Infections - Wuhan City, Hubei Province, China, 2023

Respiratory Viruses and Mycoplasma Pneumoniae Surveillance Among Hospitalized Children with Acute Respiratory Infections — Wuhan City, Hubei Province, China, September–November 2023

Immediate and Long-Term Changes in the Epidemiology, Infection Spectrum, and Clinical Characteristics of Viral and Bacterial Respiratory Infections in Western China after the COVID-19 Outbreak: a Modeling Study

Post-Pandemic Epidemiology of Respiratory Infections among Pediatric Inpatients in a Tertiary Hospital in Shanghai, China

Viral Etiology of Acute Respiratory Tract Infections in Hospitalized Children and Adults in Shandong Province, China

Viral Etiologies and Epidemiology of Patients with Acute Respiratory Infections Based on Sentinel Hospitals in Gansu Province, Northwest China, 2011‐2015

Viral etiologies of hospitalized acute lower respiratory infection patients in China, 2009-2013

Etiological and Epidemiological Features of Acute Respiratory Infections in China

Characterising respiratory infections among hospitalised children during the COVID-19 pandemic in southeastern China: a cross-sectional study of pathogens and clinical association

Prevalence of respiratory pathogens among hospitalised patients with acute respiratory infection during and after the COVID-19 pandemic in Shijiazhuang, China

Epidemiology of respiratory pathogens in patients with acute respiratory tract infection in Xiamen, China: A retrospective survey from 2020 to 2022

Analyzing infections caused by 11 respiratory pathogens in children: Pre‐ and post‐COVID‐19 pandemic trends in China

Changes in Epidemics of Respiratory Viral Infections Resulted From the COVID‐19 Pandemic in Shanghai